Is NWPHF or JEPQ a better dividend investment in 2026?

NWPHF currently yields 16.67% with a 5% 5-year dividend growth rate. JEPQ yields 11.10% with 5% growth. The better choice depends on your goal: NWPHF offers higher current income.

What is the dividend yield difference between NWPHF and JEPQ?

NWPHF has a forward dividend yield of 16.67% ($2.00/share annually). JEPQ yields 11.10% ($6.16/share annually). The yield gap is 5.57 percentage points.

Home › Compare › NWPHF vs JEPQ

NWPHF vs JEPQ: Dividend Comparison 2026

NWPHF yields 16.67% · JEPQ yields 11.10%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 NWPHF wins by $14.6K in total portfolio value

INVESTMENT

TIME HORIZON10 years

NWPHF

● Live price

16.67%

Share price

$12.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$59.4K

Annual income

$4,638.76

Full NWPHF calculator →

JEPQ

JPMorgan Nasdaq Equity Premium Income ETF

● Live price

11.10%

Share price

$55.52

Annual div

$6.16

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.8K

Annual income

$2,152.59

Full JEPQ calculator →

Portfolio growth — NWPHF vs JEPQ

📍 NWPHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	NWPHF	JEPQ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, NWPHF + JEPQ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

NWPHF pays

JEPQ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NWPHF

Annual income on $10K today (after 15% tax)

$1,416.67/yr

After 10yr DRIP, annual income (after tax)

$3,942.95/yr

JEPQ

Annual income on $10K today (after 15% tax)

$943.83/yr

After 10yr DRIP, annual income (after tax)

$1,829.70/yr

At 15% tax rate, NWPHF beats the other by $2,113.24/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NWPHF + JEPQ for your $10,000?

NWPHF: 50%JEPQ: 50%

100% JEPQ50/50100% NWPHF

Portfolio after 10yr

$52.1K

Annual income

$3,395.67/yr

Blended yield

6.52%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NWPHF buys

JEPQ buys

No recent congressional trades found for NWPHF or JEPQ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricNWPHFJEPQ

Forward yield	16.67% ✓	11.10%
Annual dividend / share	$2.00	$6.16 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$59.4K ✓	$44.8K
Annual income after 10y	$4,638.76 ✓	$2,152.59
Total dividends collected	$30.6K ✓	$16.3K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: NWPHF vs JEPQ ($10,000, DRIP)

Year	NWPHF Portfolio	NWPHF Income/yr	JEPQ Portfolio	JEPQ Income/yr	Gap
1← crossover	$12,367	$1,666.67	$11,930	$1,110.39	+$437.00 → NWPHF
2	$15,159	$1,926.27	$14,133	$1,224.34	+$1.0K → NWPHF
3	$18,426	$2,206.69	$16,632	$1,340.46	+$1.8K → NWPHF
4	$22,223	$2,506.90	$19,454	$1,457.97	+$2.8K → NWPHF
5	$26,604	$2,825.66	$22,626	$1,576.08	+$4.0K → NWPHF
6	$31,628	$3,161.43	$26,175	$1,694.09	+$5.5K → NWPHF
7	$37,355	$3,512.53	$30,133	$1,811.32	+$7.2K → NWPHF
8	$43,847	$3,877.10	$34,531	$1,927.17	+$9.3K → NWPHF
9	$51,169	$4,253.19	$39,403	$2,041.08	+$11.8K → NWPHF
10	$59,390	$4,638.76	$44,787	$2,152.59	+$14.6K → NWPHF

NWPHF vs JEPQ: Complete Analysis 2026

NWPHF — Stock

Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development of therapies for the treatment of central and peripheral nervous system, and pain in Italy and the United States. The company offers Xadago (safinamide) for the treatment of Parkinson's disease, as well as develops Xadago for the treatment of levodopa induced dyskinesia. It also develops Evenamide for Schizophrenia and treatment resistant schizophrenia; and Ralfinamide for orphan indication in neuropathic pain. Newron Pharmaceuticals S.p.A. was founded in 1999 and is headquartered in Bresso, Italy.

Full NWPHF Calculator →

JEPQ — ETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →

📬

Get this NWPHF vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NWPHF vs SCHD NWPHF vs JEPI NWPHF vs O NWPHF vs KO NWPHF vs MAIN NWPHF vs XYLD NWPHF vs QYLD NWPHF vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.